@article{22857,
  keywords = {Female, Humans, Aged, Male, Disability Evaluation, Prognosis, Time Factors, Cerebral Hemorrhage, Randomized Controlled Trials as Topic, Cerebral Ventricles, Hemorrhage, Magnetic Resonance Imaging, Neuroimaging},
  author = {INTERACT Investigators and Anderson Craig and Heeley Emma and Stapf Christian and Delcourt Candice and Robinson Thompson and Arima Hisatomi and Wang Xia and Chalmers J. and Lindley Richard and Sato Shoichiro and Carcel Cheryl and Moullaali Tom and Rabinstein Alejandro and Chen Guofang and Chan Edward and Cordonnier Charlotte},
  title = {Prognostic significance of delayed intraventricular haemorrhage in the INTERACT studies.},
  abstract = {<p>
<b>BACKGROUND AND PURPOSE: </b>Intraventricular extension of intracerebral haemorrhage (ICH) predicts poor outcome, but the significance of delayed intraventricular haemorrhage (dIVH) is less well defined. We determined the prognostic significance of dIVH in the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trials (INTERACT 1 and 2).
</p>

<p>
<b>METHODS: </b>Pooled analyses of the INTERACT CT substudies-international, multicentre, prospective, open, blinded end point, randomised controlled trials of patients with acute spontaneous ICH and elevated systolic blood pressure (SBP)-randomly assigned to intensive (&lt;140 mm Hg) or guideline-based (&lt;180 mm Hg) SBP management. Participants had blinded central analyses of baseline and 24 h CTs, with dIVH defined as new intraventricular haemorrhage (IVH) on the latter scan. Outcomes of death and major disability were defined by modified Rankin Scale scores at 90 days.
</p>

<p>
<b>RESULTS: </b>There were 349 (27%) of 1310 patients with baseline IVH, and 107 (11%) of 961 initially IVH-free patients who developed dIVH. Significant associations of dIVH were prior warfarin anticoagulation, high (≥15) baseline National Institutes of Health Stroke Scale score, larger (≥15 mL) ICH volume, greater ICH growth and higher achieved SBP over 24 h. Compared with those who were IVH-free, dIVH had greater odds of 90-day death or major disability versus initial IVH (adjusted ORs 2.84 (95% CI 1.52 to 5.28) and 1.87 (1.36 to 2.56), respectively (p trend &lt;0.0001)).
</p>

<p>
<b>CONCLUSIONS: </b>Although linked to factors determining greater ICH growth including poor SBP control, dIVH is independently associated with poor outcome in acute small to moderate-size ICH.
</p>

<p>
<b>TRIAL REGISTRATION NUMBERS: </b>NCT00226096 and NCT00716079.
</p>
},
  year = {2017},
  journal = {J Neurol Neurosurg Psychiatry},
  volume = {88},
  pages = {19-24},
  issn = {1468-330X},
  doi = {10.1136/jnnp-2015-311562},
  language = {eng},
}